- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03931187
Double ABCX Theory Based Cognitive Psychotherapy Combined Progressive Muscle Relaxation Intervention on Women Undergoing IVF-ET
November 30, 2021 updated by: Anni Wang, Central South University
Double ABCX Theory Based Cognitive Psychotherapy Combined Progressive Muscle Relaxation Intervention on Women Undergoing In Vitro Fertilization-Embryo Transfer Treatment
The in vitro fertilization and embryo transfer(IVF-ET) is a therapy to help the infertile couples.
The mental health status of couple under IVF-ET, commonly seen in depression and anxiety, is found to be closely related to the success of IVF-ET.
This study aims to develop a intervention program combing cognitive psychotherapy and progressive muscle relaxation to ease the negative emotion and promote the success rate among couples undergoing IVF-ET.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
67
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hunan
-
Changsha, Hunan, China, 410013
- Infertility Reproductive Center, Second Xiangya Hospital, Central South University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The couple who are eligible for in vitro fertilization-embryo transfer (IVF-ET) treatment;
- Junior high school and above;
- voluntarily accepted for investigation and signed informed consent.
Exclusion Criteria:
- Suffering from physical diseases such as severe heart, liver and kidney, and mental disorders;
- Experiencing major traumatic events in the past 2 years.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Women intervention arm
Intervention will be applied to the women within the couple.
|
This therapy combines cognitive psychotherapy and progressive muscular relaxation, intervened 6 times with 1-1.5 hour each time.
The whole therapy will last round 28-30 days during IVF-ET.
|
Experimental: Couple intervention arm
Intervention will be applied to the couple, both men and women.
|
This therapy combines cognitive psychotherapy and progressive muscular relaxation, intervened 6 times with 1-1.5 hour each time.
The whole therapy will last round 28-30 days during IVF-ET.
|
No Intervention: Control arm
The couple will receive the normal nursing care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of depression score
Time Frame: The investigators will measure the socre of depression at baseline and immediately after intervention ( the duration of intervention is around 1 month).
|
The Self-reported Depression Scale (SDS)will be used to assess the score of depression.The total score of SDS ranges from 0-80, with 40 as the cutoff.
The higher the total score, the more depressive.
|
The investigators will measure the socre of depression at baseline and immediately after intervention ( the duration of intervention is around 1 month).
|
Change of anxiety score
Time Frame: The investigators will measure the socre of anxiety at baseline and immediately after intervention ( the duration of intervention is around 1 month).
|
The Self-reported Anxiety Scale (SAS) will be used to assess the score of anxiety.The total score of SAS ranges from 0-80, with 30 as the cutoff.
The higher the total score, the more anxious.
|
The investigators will measure the socre of anxiety at baseline and immediately after intervention ( the duration of intervention is around 1 month).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Blood Cortisol
Time Frame: The investigators will measure the socre of Blood Cortisol at baseline and immediately after intervention ( the duration of intervention is around 1 month).
|
This is a kind of hormone closely related to stress, and the investigators will measure the level of Blood Cortisol by Blood test.
|
The investigators will measure the socre of Blood Cortisol at baseline and immediately after intervention ( the duration of intervention is around 1 month).
|
Change of sleeping quality
Time Frame: The investigators will measure the socre of sleeping quality at baseline and immediately after intervention ( the duration of intervention is around 1 month).
|
The physical condition closely related to stress.
The investigators will use Self-Rating Scale of Sleep to measure the sleeping quality of the participants.
The total sore ranges from 5 to 50, with higher score reflects better sleep quality.
|
The investigators will measure the socre of sleeping quality at baseline and immediately after intervention ( the duration of intervention is around 1 month).
|
Successful conception rate (%)
Time Frame: The doctor will test whether it is successfully conceived 4 weeks after the embryo is implanted. The last intervention is on the day of embryo implantation. The investigators will count this 4 weeks after completion of intervention.
|
The investigators will count the successful conception rate at each arms.
|
The doctor will test whether it is successfully conceived 4 weeks after the embryo is implanted. The last intervention is on the day of embryo implantation. The investigators will count this 4 weeks after completion of intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2018
Primary Completion (Actual)
May 1, 2019
Study Completion (Actual)
July 1, 2019
Study Registration Dates
First Submitted
April 23, 2019
First Submitted That Met QC Criteria
April 25, 2019
First Posted (Actual)
April 30, 2019
Study Record Updates
Last Update Posted (Actual)
December 14, 2021
Last Update Submitted That Met QC Criteria
November 30, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Intervention on IVF-ET
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The participants are not willing to share the data.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Cognitive progressive muscular relaxation therapy
-
Université de MontréalLaval University; RRISIQCompletedHIV | Depressive SymptomsCanada
-
Riphah International UniversityCompletedHypertensionPakistan
-
University of PadovaCompletedDepression | Quality of Life | Anxiety | Stress, Emotional | Coping SkillsItaly
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Instituto de Investigación Marqués de ValdecillaRecruiting
-
Duquesne UniversityMilton S. Hershey Medical CenterCompletedHIV Infections | Adverse EffectsUnited States
-
Necmettin Erbakan UniversityCompletedInfertility, FemaleTurkey
-
El Instituto Nacional de Neurologia y Neurocirugia...CompletedPost Traumatic Stress Disorder | Trauma, PsychologicalMexico
-
Istanbul Saglik Bilimleri UniversityCompleted
-
Ataturk UniversityCompletedStress | Anxiety | Nursing Students | Relaxation ProgramTurkey